PubMed

Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.

Bode BW, Strange P.

Diabetes Care. 2001 Jan;24(1):69-72.PMID: 11194244 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.

Bode B, Weinstein R, Bell D, McGill J, Nadeau D, Raskin P, Davidson J, Henry R, Huang WC, Reinhardt RR.

Diabetes Care. 2002 Mar;25(3):439-44.PMID: 11874927 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump.

Raskin P, Holcombe JH, Tamborlane WV, Malone JI, Strowig S, Ahern JA, Lavent F.

J Diabetes Complications. 2001 Nov-Dec;15(6):295-300.PMID: 11711322 [PubMed - indexed for MEDLINE]Related articles

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW; Insulin Aspart CSII/MDI Comparison Study Group.

Diabetes Care. 2005 Mar;28(3):533-8.PMID: 15735183 [PubMed - indexed for MEDLINE]Related articlesFree article

Spotlight on insulin aspart in type 1 and 2 diabetes mellitus.

Chapman TM, Noble S, Goa KL.

Treat Endocrinol. 2003;2(1):71-6. Review.PMID: 15871555 [PubMed - indexed for MEDLINE]Related articles

Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

Renner R, Pfützner A, Trautmann M, Harzer O, Sauter K, Landgraf R.

Diabetes Care. 1999 May;22(5):784-8.PMID: 10332682 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.

Bode BW.

Clin Ther. 2007;29 Suppl D:S135-44.PMID: 18191065 [PubMed - indexed for MEDLINE]Related articles

A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.

Bi YF, Zhao LB, Li XY, Wang WQ, Sun SY, Chen YH, Hong J, Su TW, Liu JM, Ning G.

Chin Med J (Engl). 2007 Oct 5;120(19):1700-3.PMID: 17935674 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA.

Diabetologia. 2004 Apr;47(4):622-9.PMID: 15298338 [PubMed - indexed for MEDLINE]Related articles

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.

Hollander P, Cooper J, Bregnhøj J, Pedersen CB.

Clin Ther. 2008 Nov;30(11):1976-87.PMID: 19108786 [PubMed - indexed for MEDLINE]Related articles

A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes.

Weinzimer SA, Ternand C, Howard C, Chang CT, Becker DJ, Laffel LM; Insulin Aspart Pediatric Pump Study Group.

Diabetes Care. 2008 Feb;31(2):210-5. Epub 2007 Nov 5.PMID: 17989308 [PubMed - indexed for MEDLINE]Related articlesFree article

Benefits of insulin aspart vs phosphate-buffered human regular insulin in persons with type 1 Diabetes treated by means of an insulin pump.

Chlup R, Zapletalová J, Seckar P, Chlupová L, Táncosová S, Reznícková M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004 Jul;148(1):27-32.PMID: 15523542 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.

Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.

Diabetes Care. 2000 Sep;23(9):1232-5.PMID: 10977011 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.

Chapman TM, Noble S, Goa KL.

Drugs. 2002;62(13):1945-81. Review. Erratum in: Drugs. 2003;63(5):512.. PMID: 12215068 [PubMed - indexed for MEDLINE]Related articles

Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.

Reynolds NA, Wagstaff AJ.

Drugs. 2004;64(17):1957-74. Review.PMID: 15329046 [PubMed - indexed for MEDLINE]Related articles

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

Home PD, Lindholm A, Riis A; European Insulin Aspart Study Group.

Diabet Med. 2000 Nov;17(11):762-70.PMID: 11131100 [PubMed - indexed for MEDLINE]Related articles

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.PMID: 18158078 [PubMed - indexed for MEDLINE]Related articles

Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.

Attia N, Jones TW, Holcombe J, Tamborlane WV.

Diabetes Care. 1998 May;21(5):817-21.PMID: 9589247 [PubMed - indexed for MEDLINE]Related articlesFree article

Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR.

Diabetes Care. 2003 Sep;26(9):2598-603.PMID: 12941725 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes.

Pieber TR, Eugène-Jolchine I, Derobert E.

Diabetes Care. 2000 Feb;23(2):157-62.PMID: 10868824 [PubMed - indexed for MEDLINE]Related articlesFree article